How AI can accelerate the search for treatments for emerging and intractable diseases
Artificial intelligence (AI) models and algorithms can save time and money in the search for drug candidates for emerging diseases, including COVID-19.
Joanna is passionate about creating responsible technology that benefits humanity. She has spent her professional life building companies, products and platforms that have transformed markets and reshaped industries. She is CEO of BenevolentAI since 2018 and has accelerated the company’s growth and transformation from a startup to a clinical-stage, AI-enabled drug discovery company. Joanna has over three decades of experience leading some of the world's best known technology companies, including Facebook, Bebo/Aol and Google. Prior to joining BenevolentAI, Joanna served in the UK Government as Under Secretary of State and Minister for Internet Safety & Security, Digital Economy Adviser, UK Ambassador for Digital Industries and Chair/CEO of TechCityUK. Joanna is the founder of the WeProtect Global Alliance, serves as the Co-Chair of the Global Partnership on Artificial Intelligence (GPAI) and is a Life Peer of the House of Lords.